Molecular Biomedicine

Springer

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Molecular Biomedicine is an open-access journal published by Springer in Switzerland, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,490 EUR. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer
ISSN
2662-8651
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
2,490 EUR
Articles in DOAJ
550
Declared review time
10 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2020-11-10
  • MEDLINE · 2024-01-01
  • PUBMED · 2020-08-06
Indexing
DOAJ · MEDLINE · PUBMED
APC
2,490 EUR
Declared review time (DOAJ)
10 weeks
Actual review time (measured)
230 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

550

Most recent article

last month

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

488

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

45

i10-index

183

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-03-17
Added to DOAJ
2020-11-10
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPorticoPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
70%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918283581406676
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Immune cells in cancer
  • Immune cells in cancer
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • SARS-CoV-2 and COVID-19 Research
  • RNA modifications and cancer
Show all subjects (50)
  • SARS-CoV-2 and COVID-19 Research
  • Ferroptosis and cancer prognosis
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Cancer-related molecular mechanisms research
  • Cancer Cells and Metastasis
  • interferon and immune responses
  • Cancer Cells and Metastasis
  • Immunotherapy and Immune Responses
  • Cancer-related molecular mechanisms research
  • Cancer, Hypoxia, and Metabolism
  • Cancer Genomics and Diagnostics
  • Inflammasome and immune disorders
  • Immunotherapy and Immune Responses
  • Inflammasome and immune disorders
  • Extracellular vesicles in disease
  • interferon and immune responses
  • Cancer Genomics and Diagnostics
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • MicroRNA in disease regulation
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • Cancer-related gene regulation
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • RNA Research and Splicing
  • Cancer-related gene regulation
  • RNA Research and Splicing
  • Autophagy in Disease and Therapy
  • Gut microbiota and health
  • Gut microbiota and health
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • Endoplasmic Reticulum Stress and Disease
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • CRISPR and Genetic Engineering
  • Autophagy in Disease and Therapy

Keywords (DOAJ)

  • biomedicine
  • genetics
  • bioinformatics
  • molecular biology
  • gene editing

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: